News from the lab

Our group merges chemical and biological approaches into a cohesive research program. We explore the intersection of chemistry and immunology, with a particular focus on harnessing the power of adaptive immune responses and functional antibody design. Our diverse research interests entail catalytic antibody development, biochemical reactivity of drugs of abuse and immunopharmacotherapy for drug abuse, regulation of body weight and metabolism, detection of and protection from warfare agents, bacterial cell-cell communication, phage display technology, neglected tropical disease diagnostics and therapeutics as well as organic synthesis methods.

The information on the Janda Lab website represents that of the author and not that of Scripps Research. The Janda Lab takes full responsibility for the information presented. Accidental errors will be corrected in a timely manner.

New PLD4 study available online now

New "zombie drug" study available online now

Chemistry World ran a great story covering our D4CC00883A paper

The San Diego Union Tribune published an article about our "zombie" drug paper